| 调血脂药物的临床应用现状与研究进展 |
| |
| 引用本文： | 李犁,杜晓红,张建瑞,王瑞芳,武爱民. 调血脂药物的临床应用现状与研究进展[J]. 基层医学论坛, 2012, 16(25): 3360-3362 |
| |
| 作者姓名： | 李犁 杜晓红 张建瑞 王瑞芳 武爱民 |
| |
| 作者单位： | 包头市北方医院,内蒙古,包头,014030 |
| |
| 摘 要： | 动脉粥样硬化性心脑血管病是世界范围内的主要死亡原因之一,血脂异常是动脉粥样硬化最重要的危险因素之一。目前临床常用的调血脂药物包括他汀类、烟酸类、贝特类、胆酸螯合剂、胆固醇吸收抑制剂及天然有效成分等,基因疗法在不久的将来很可能会应用到临床。调脂药物规范化、合理化、个体化的临床应用将在心脑血管疾病防治方面发挥重要作用。
|
| 关 键 词： | 调血脂药物 临床应用 现状 进展 |
Research progress and clinical application of lipid-regulatory drugs |
| |
| Affiliation: | Li Li,Du Xiaohong,Zhang Jianrui,et al.The Third Affiliated Hospital of Baotou Medical College,Baotou,Neimenggu 014030 |
| |
| Abstract: | Coronary Atherosclerotic cardiovascular and cerebrovasular diseases are one of the main causes resulting in death in the word.Lipid disorder is one of the most important risk factos of artherosclerosis.The lipid-regulatory drugs common used in Clinical are drugs belonging to Statins,Nicotinic acids,Brates,Bile acid sequestrant,Cholesterol absorption inhibitors,Natural and effective ingredients and so on.Gene therapy will be used in clinical in the near future.Clinical application lipid-lowering drugs with standardized,rationalized,individualized will play an important role in prevention cardiovascular or cerebrovasular disease. |
| |
| Keywords: | Lipid-regulatory drugs Clinical application Status quo Progress |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
